TC Biopharm ()

0.01
-0.00 (-18.03%)
At close: Mar 04, 2025, 9:38 AM

TC Biopharm () Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -41.71 -532.81 -721.03 -2.55K -2.37K
PEG Ratio 0.83 5.64 -4.04 266.28 n/a
PS Ratio n/a 182.05 4.95K 7.04K 4.19K
PB Ratio 91.76 2.11K -591.13 -4.16K -5.65K
P/FCF Ratio -23.12 -45.06 -1.75K -4.02K -1.64K
P/OCF Ratio -23.37 -45.77 -1.75K -4.06K -2.13K
OCF/S Ratio n/a -3.98 -2.82 -1.73 -1.96
Debt / Equity Ratio 0.67 7.40 -0.96 -0.77 -1.19
Quick Ratio 1.20 0.81 0.19 0.53 1.09
Current Ratio 1.20 0.81 0.19 0.53 1.09
Asset Turnover n/a 0.34 0.25 0.27 0.34
Interest Coverage n/a -1.79 -2.12 -23.58 -24.11
Return on Equity (ROE) -2.2 -3.97 0.82 1.63 2.39
Return on Assets (ROA) -0.66 -0.12 -1.69 -0.75 -0.6
Return on Capital (ROIC) -3.41 -5.68 0.58 -2.24 -1.06
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a 100.00% 100.00% 100.00% 100.00%
Net Profit Margin n/a -34.17% -686.12% -275.84% -177.07%
Pretax Profit Margin n/a -78.91% -757.25% -335.07% -201.18%
Operating Profit Margin n/a -314.32% -368.28% -348.05% -193.78%
FCF Margin n/a -404.03% -283.07% -175.21% -255.52%
EBITDA Margin n/a -294.48% -327.25% -265.97% -172.71%